During this time of unprecedent uncertainty, the public have come to understand the importance of Clinical Research as the most prominent tool in developing treatments and vaccines to fight COVID-19; in that sense, we are proud to be proactively working in the Research field, now, more than ever.
BRCR Global, has been actively monitoring the outbreak of COVID-19 in every country where we have operations, we are committed to doing our part to limit the spread of infection but most important we are committed assuring the safety of trial participants, maintaining compliance with Good Clinical Practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.
We have transitioned to home-based activities for administrative, business development and finance staff in order to limit the number of people on site and to minimize the health risks for our patients and staff; also, promoting social distancing, which health experts have advised is the best way of limiting infection of COVID-19.
For ongoing studies, Principal Investigators and all of our clinical operations staff, will continue to work following CDC, FDA and IRB guidance as well as local announcements by authorities and governments. Constant communication with Sponsors is part of the current daily activities evaluating each study in the light of the circumstances. We are encouraging for Site Visits to be performed remotely. We are committed to help subjects who are currently enrolled in all of our studies, their relatives and professionals who provide health care for them to stay safe during the current COVID-19 pandemic.
We are devoted in our goal to establish sustainable research projects that will have a great impact in the medical community worldwide.
We have extensive experience in a variety of therapeutic areas by managing studies in USA, Latin America, Caribbean Islands and Central America. We have built strong business relationships with main researchers in several cities in the referred regions.
Contact Us